< Back to all clusters
[HEALTH] · Spain · 9 sources

Anal Cancer: Rare Tumor Often Mistaken for Hemorrhoids, Risks and Diagnosis Details

Anal cancer is a rare disease, representing less than 1 percent of all diagnosed cancers and about 2‑3 percent of gastrointestinal tumours. Its annual incidence is roughly 1‑2 cases per 100,000 people, with a gradual rise observed over the past four decades.

The condition predominantly affects individuals over 50 years old and is twice as common in women as in men. Approximately 90 percent of cases are linked to infection with human papillomavirus (HPV), especially genotypes 16 and 18. Major risk factors include a high number of sexual partners, anal intercourse, a history of genital warts or lower genital tract cancers, tobacco use, and immunosuppression. People living with HIV have a 30‑100‑fold increased risk, as do organ‑transplant recipients on immunosuppressive therapy.

Diagnosing anal cancer is challenging because its symptoms—rectal bleeding, pain, itching, or discharge—mimic benign anorectal conditions such as hemorrhoids, anal fissures, and pruritus. Dr Pilar García Alfonso, head of the Medical Oncology Section at Hospital General Universitario Gregorio Marañón in Madrid and member of the Spanish Group for Digestive Tumour Treatment (TTD), stresses that a high index of suspicion is essential for early detection.

Entities

Grupo Español de Tratamiento de Tumores Digestivos · Hospital General Universitario Gregorio Marañón · Human Immunodeficiency Virus (HIV) · Human Papillomavirus (HPV) · Pilar García Alfonso

Claims

What the coverage asserts, and how many sources carry each claim.